Reminder: T3 Labs is now part of GCMI. The relationship supports our mission driven ability to help direct the development, testing, training and commercialization of innovative medical products. Follow @medtechinnovate and GCMI on LinkedIn. https://t.co/GeSJABETfH
ICYMI: As the the Cycle II R01 & R03 deadlines are quickly approaching, see how we can help you with the #preclinical section of your #grant application. You can contact us at [email protected] or [email protected] https://t.co/zOmc4BapIE
A/S Fleming tours T3 labs @medtechinnovate on the @GeorgiaTech Technology Enterprise Park campus. GCMI is the Southeast's first comprehensive medical device innovation center and, proudly, an EDA RIS grantee: https://t.co/GK61DYvBL4
T3 Labs Orthopedic Program Director, Evan Goldberg attended the 2019 AAOS Meeting earlier this month to keep touch with the pulse of #orthopedic innovation. Here are Evan’s top takeaways. #AAOS2019 https://t.co/W6aucN7k0o
Last year, Ares Health Systems became the first #digitalhealth company to enter GCMI’s accelerator. See what Ares CEO Martin Entwistle has to say about the accelerator program and the development of their MPower #caremanagement platform. https://t.co/FbhvbncRLt
The New York Times recently mentioned the work that GCMI and the American Cancer Society are doing to help bring BOTLab’s NIR #technology to bear on real-time verification of chemotherapy effectiveness for breast cancer patients. #medtech https://t.co/l4K8Vc89fO
If you have an idea for a new #orthopedic device, T3 Labs will be at #AAOS2019 to answer any questions you have about market assessment, regulatory pathway, design and development, #preclinical testing, and commercialization. https://t.co/3HrUGqwrVd
If you have an idea for a new #orthopedic device, T3 Labs will be at #AAOS2019 to answer any questions you have about market assessment, regulatory pathway, design and development, #preclinical testing, and commercialization. https://t.co/3HrUGqwrVd
Join GCMI and the Greenlight Guru team on March 7th for a night of learning, networking, drinks, and hors d’oeuvres. We’ll be discussing the regulatory paradigm shift happening at FDA with their Case for Quality and more. Get your free ticket today! https://t.co/nJsaflGTZc
Ares Health Systems CEO Martin Entwistle and GCMI Executive Director Andrew Stevenson recently braved #HIMSS19. Here are their top insights and thoughts about the shift in CMS’ leadership on the subject of #interoperability and patient access to data. https://t.co/50n4hkd9LB
GCMI and Rambam Medical Center were just named the winner of the @Georgia_Bio 2019 Phoenix Award, recognizing their #innovation and leadership in the community! #medtech https://t.co/oVoWwXrBpP
GCMI Executive Director Andrew Stevenson and Ares Health Systems CEO Martin Entwistle will be attending #HIMSS19 to discuss GCMI’s “A1” accelerator program and to see the latest in #healthcare information and #technology. https://t.co/JfTGT7Dmid
GCMI engineers Sarah Cohen and Dersi Patel have joined the global medical manufacturing community at MD&M West. Make sure to stop by and see them at Booth #1093! @MDM_Events #MDMWest2019#AdvMfgExpo
In case you missed it: Here are our top insights from the most recent AdvaMed Medtech Conference, the #medtech industry’s leading event. https://t.co/qPsJVgZr0D
GCMI CEO @TheTifWilson shares her JP Morgan 2019 insights, advice and a look ahead to 2020 in this Q&A about the biggest event in the business of #healthcare. #JPM19 https://t.co/WaRTqjkZ11
Tiffany Wilson will be joining the @Angel_Atlanta session on Jan. 28 to discuss top trends in #medtech and the challenges that early stage companies are facing as they move from concept to commercialization. https://t.co/ln6L7A6kXY
Sky Magazine explored the Southeast #medtech innovation ecosystem while speaking with GCMI and T3 Labs CEO Tiffany Wilson about the resources available to medical device innovators and startups in #Atlanta. https://t.co/s0LxCiyYuC